Bienvenue sur le forum TechNet

Échangez, posez des questions, trouvez des réponses et partagez vos connaissances avec la communauté mondiale de la vaccination

Discussions à la une

We're excited to announce a two-part webinar series dedicated to the Vaccine Vial Monitor (VVM), the simple yet transformative tool that has helped ensure vaccine potency worldwide for three decades. Session 1: 30 Years of VVM: A RetrospectiveJoin us for a look back at three decades of the VVM, f...
The World Health Organization (WHO) has launched the new Implementing integrated health campaigns: decision-making and planning guide (available in English and French), which provides a practical framework to help countries assess opportunities for campaign integration and plan integrated health cam...
Gender-related barriers continue to affect equitable access to immunization services and outcomes. Addressing these barriers is essential to improving coverage, reaching zero-dose children, and ensuring that no one is left behind. Join us on 13 October 2026 for the launch webinar of the n...

Discussions

Dear Friends, Here is more on intradermal Influenza vaccine: http://www.ncbi.nlm.nih.gov/pubmed/18652550                 http://content.nejm.org/cgi/content/full/351/22/2286 The government of India is importing 2.8 million ...
Dear Friends, After Virorab, Sanofi-Pasteur has come out with a low-cost Intradermal Influenza vaccine Intanza® / IDflu® vaccine*, see the link below, http://198.73.159.214/sanofi-pasteur2/ImageServlet?imageCode=24890&siteCode=SP_CORP Dr. Omesh BhartiM.B.B.S.,D.H.M.,M.A.E.(Epidemiology)Dir...
Dear Friends, It is a great pleasure to know that now Virorav has also come out with the intradermal option (attachment). This will be a further boost to the intradermal ARV campaign in India to controll rabies. After Rabipur, Abhyrab and Indirav, this will be the fourth drug offer...
Dear Technet Subscribers, I have attached a study conducted in Pakistan on the use of re-designed immunization cards, in an attempt to provide relief from the almost exclusively CC and logistics focus of Technet's recent discussions (shades of the old Technet, when cold chain ruled!) Cheers, Tasnim ...
We would like to share a report on intradermal delivery of vaccines that was commissioned by PATH's Disposable Jet Injector Project and Project Optimize (a collaborative project between WHO and PATH). The report was authored by Julian Hickling and Rebecca Jones from Working in Tandem Ltd. The purpo...
Michel and others, Thanks for suggesting two different discussion tracks. Pioneers in EPI logistics such as yourself, James Cheyne, Modibo Dicko, John Lloyd have done and continue to do a formidable job of improving storage conditions, creating VVMs, creating transportation systems to reach geo...
Today, most vaccines are licensed for storage between 2-8°C, regardless of their true stability. While there are some vaccines that do need to be kept at this specific temperature range, studies have shown that most vaccines are able to withstand higher temperature ranges for a specific period of ti...
Dear Friends, The introduction of the pentavalent vaccine will further eat into the health budget as shown by Natasha Hsi, Abt Associates, Katherine Wolf, Emory University, Global Health Council (June 2, 2005). The study says that, with the introduction of the pentavalnent vaccine, the cost of routi...
Dear Moderator, I just wanted to know through you, if the same technology can be available for DPT or pentavalent vaccine, so that remote areas could be served well. Dr. Omesh BhartiM.B.B.S.,D.H.M.,M.A.E.(Epidemiology) Directorate of Health Safety and Regulation,Himachal Pra...
In partnership with Arecor and the University of Colorado Denver School of Pharmacy, PATH published findings in this month’s issue of Human Vaccines (volume 5, issue 8) that describe a new hepatitis B vaccine formulation exhibiting nine week stability at 55°C and at least six month stability at both...
http://WWW.VACCINEINDIA.ORG Almost half India’s children are not immunised ONLY 54.1 per cent of India's children are fully immunised. The other half -- this includes the 11.3 per cent who never received any form of vaccination -- run the risk of disease as they have failed to complete even the basi...
Long-term Cold Storage Containers and Carriers for Heat/Freeze-sensitive Vaccines: Target Performance Criteria by Steve McCarney, PATH Project Optimize, a collaboration between the World Health Organization (WHO) and PATH, seeks to develop and galvanize support around a vision for the future of i...
by Steve McCarney, PATH Chihuahua, Mexico, just south of the US border, is so predictably sunny, one hardly needs to consult a newspaper to predict the weather. Chances are it will be sunny and dry. A few hours south, in Mexico City, the weather is more temperate and cloud cover more frequent dur...
Tunisia Explores New Supply Chain Solutions for Health by Patrick Lydon, WHO After several preliminary discussions, World Health Organization (WHO) and PATH will collaborate on a project with the Ministry of Health in Tunisia to demonstrate and validate: (a) approaches that address anticipated ch...
Is That a Toyota Prius in Your Refrigerator? by Steve McCarney, PATH Solar refrigeration has been a promising technology for rural health outposts in developing countries for two decades, but it has one fatal flaw: the batteries tend to die long before the rest of the system is ready to give up. ...
Senegal To Explore Integrated Supply Chains and New Delivery Models by Modibo Dicko, WHO; Dr. Aboubakry Fall, Ministry of Public Health Senegal; and Dr. Ndiouga Diallo, PATH Optimize is discussing an agreement with the Ministry of Health in Senegal to explore several new approaches to supply chai...
Dear Friends, Recently there have been a number of articles critical of the recommendations for pneumococcal and the pentavalent vaccines in high impact journals. I understand some of this has spilled over to the lay press and it will be good if we can have clarity on these issu...
Oral Polio Delivered Safely Without Icepacks in Recent Study by Ariane Halm, EPIET (European Programme for Intervention Epidemiology Training), and Olivier Ronveaux, WHO Optimizerecently completed a study with the World Health Organization (WHO) Country Office and the Ministry of Health in Mali to ...
In the course of the revision of the WHO Multi-dose Vial Policy (MDVP) we came across the question if there were any vaccines in multidose vials that had to be discarded less than 6 hours after having been opened. Some package inserts seem to indicate this, but it is not clear whether it would deter...
Temperature Monitoring Study To Commence in Vietnam and Uganda by Joanie Robertson, Huong Vu and James Cheyne, PATH While some vaccines will lose their potency if they are stored at temperatures above or below the standard 2° to 8°C, many vaccines are quite heat stable and can tolerate temperatures...
Il n'existe aucune discussion disponible ici